BeOne Medicines - SG&A Expenses 2014-2026 | ONC

BeOne Medicines - annual/quarterly sg&a expenses history and growth rate from 2014 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

BeOne Medicines - sg&a expenses for the quarter ending March 31, 2026 were $0.555B, a 20.86% increase year-over-year.
BeOne Medicines - sg&a expenses for the twelve months ending March 31, 2026 were $2.177B, a 16.88% increase year-over-year.
BeOne Medicines - annual sg&a expenses for 2025 were $2.081B, a 13.68% increase from 2024.
BeOne Medicines - annual sg&a expenses for 2024 were $1.831B, a 21.42% increase from 2023.
BeOne Medicines - annual sg&a expenses for 2023 were $1.508B, a 18.01% increase from 2022.

BeOne Medicines - Annual SG&A Expenses (Millions of US $)
2025	$2,081
2024	$1,831
2023	$1,508
2022	$1,278
2021	$990
2020	$600
2019	$388
2018	$195
2017	$63
2016	$20
2015	$7
2014	$7
2013	$3

BeOne Medicines - Quarterly SG&A Expenses (Millions of US $)
2026-03-31	$555
2025-12-31	$555
2025-09-30	$529
2025-06-30	$538
2025-03-31	$459
2024-12-31	$505
2024-09-30	$455
2024-06-30	$444
2024-03-31	$427
2023-12-31	$419
2023-09-30	$366
2023-06-30	$395
2023-03-31	$328
2022-12-31	$329
2022-09-30	$323
2022-06-30	$331
2022-03-31	$295
2021-12-31	$307
2021-09-30	$269
2021-06-30	$232
2021-03-31	$182
2020-12-31	$208
2020-09-30	$161
2020-06-30	$124
2020-03-31	$107
2019-12-31	$143
2019-09-30	$105
2019-06-30	$82
2019-03-31	$58
2018-12-31	$72
2018-09-30	$49
2018-06-30	$45
2018-03-31	$29
2017-12-31	$27
2017-09-30	$16
2017-06-30	$11
2017-03-31	$9
2016-12-31	$8
2016-09-30	$5
2016-06-30	$4
2016-03-31	$3
2015-12-31	$3
2015-09-30
2015-06-30	$1
2015-03-31	$1
2014-12-31
2013-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$33.976B	$5.343B
BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.845B	31.38
UCB SA (UCBJY)	Belgium	$60.713B	0.00
Takeda Pharmaceutical (TAK)	Japan	$57.538B	11.30
Zoetis (ZTS)	United States	$49.577B	18.36
Sandoz Group AG (SDZNY)	Switzerland	$37.136B	0.00
Otsuka Holdings, - (OTSKY)	Japan	$36.393B	14.73
Daiichi Sankyo, - (DSNKY)	Japan	$33.284B	16.12
Astellas Pharma (ALPMY)	Japan	$29.805B	11.68
United Therapeutics (UTHR)	United States	$25.058B	20.49
Shionogi (SGIOY)	Japan	$18.069B	13.97
Merck (MKKGY)	Germany	$16.944B	11.65
IPSEN (IPSEY)	France	$16.273B	0.00
Summit Therapeutics (SMMT)	United States	$15.264B	0.00
Neurocrine Biosciences (NBIX)	United States	$12.936B	27.96
Ionis Pharmaceuticals (IONS)	United States	$12.417B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.920B	0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF)	Italy	$11.749B	16.23
Orion OYJ (ORINY)	Finland	$10.723B	18.62
Eisai (ESAIY)		$9.158B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.834B	16.35
Centessa Pharmaceuticals (CNTA)	United Kingdom	$6.102B	0.00
Grifols, S.A (GRFS)	Spain	$5.588B	0.00
Corcept Therapeutics (CORT)	United States	$4.458B	51.11
Crinetics Pharmaceuticals (CRNX)	United States	$4.130B	0.00
Stevanato Group S.p.A (STVN)	Italy	$4.094B	22.53
NewAmsterdam Pharma (NAMS)	Netherlands	$3.997B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.945B	16.50
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$3.838B	0.00
Indivior Pharmaceuticals (INDV)	United States	$3.724B	12.41
Hypermarcas (HYPMY)	Brazil	$3.308B	13.82
Dyne Therapeutics (DYN)	United States	$3.086B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.046B	9.86
Oruka Therapeutics (ORKA)	United States	$2.952B	0.00
Soleno Therapeutics (SLNO)	United States	$2.717B	228.83
Enliven Therapeutics (ELVN)	United States	$2.710B	0.00
Relay Therapeutics (RLAY)	United States	$2.670B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.479B	41.65
BioCryst Pharmaceuticals (BCRX)	United States	$2.398B	7.19
Nektar Therapeutics (NKTR)	United States	$2.223B	0.00
Definium Therapeutics (DFTX)	United States	$2.147B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.113B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.096B	19.46
Ocular Therapeutix (OCUL)	United States	$1.914B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.808B	0.00
Ardelyx (ARDX)	United States	$1.516B	0.00
Harrow (HROW)	United States	$1.338B	79.84
Savara (SVRA)	United States	$1.158B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.149B	5.37
Xeris Biopharma Holdings (XERS)	United States	$1.009B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.993B	0.00
Cronos Group (CRON)	Canada	$0.971B	0.00
Evotec AG (EVO)	Germany	$0.935B	0.00
Xencor (XNCR)	United States	$0.911B	0.00
Aktis Oncology (AKTS)	United States	$0.901B	0.00
Theravance Biopharma (TBPH)	United States	$0.842B	21.80
ARS Pharmaceuticals (SPRY)	United States	$0.799B	0.00
Relmada Therapeutics (RLMD)	United States	$0.765B	0.00
Bioventus (BVS)	United States	$0.753B	13.32
Ironwood Pharmaceuticals (IRWD)	United States	$0.592B	15.78
ProKidney (PROK)	United States	$0.589B	0.00
Esperion Therapeutics (ESPR)	United States	$0.557B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.556B	9.19
Rigel Pharmaceuticals (RIGL)	United States	$0.540B	4.49
Lyell Immunopharma (LYEL)	United States	$0.522B	0.00
Larimar Therapeutics (LRMR)	United States	$0.504B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.501B	0.00
Aquestive Therapeutics (AQST)	United States	$0.498B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.487B	0.00
Nature's Sunshine Products (NATR)	United States	$0.471B	21.37
Lexeo Therapeutics (LXEO)	United States	$0.443B	0.00
Altimmune (ALT)	United States	$0.422B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.409B	37.99
Century Therapeutics (IPSC)	United States	$0.404B	0.00
Akebia Therapeutics (AKBA)	United States	$0.375B	0.00
USANA Health Sciences (USNA)	United States	$0.334B	9.43
AleAnna (ANNA)	United States	$0.333B	124.75
Surrozen (SRZN)	United States	$0.324B	0.00
Siga Technologies (SIGA)	United States	$0.312B	14.06
Avalo Therapeutics (AVTX)	United States	$0.311B	0.00
Organogenesis (ORGO)	United States	$0.306B	8.81
Silence Therapeutics (SLN)	United Kingdom	$0.271B	0.00
Cybin (HELP)	Canada	$0.270B	0.00
Protara Therapeutics (TARA)	United States	$0.268B	0.00
Prelude Therapeutics (PRLD)	United States	$0.257B	0.00
Minerva Neurosciences (NERV)	United States	$0.238B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.230B	0.00
MediWound (MDWD)	Israel	$0.229B	0.00
Context Therapeutics (CNTX)	United States	$0.229B	0.00
Enlivex (ENLV)	Israel	$0.228B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.224B	0.00
Profound Medical (PROF)	Canada	$0.216B	0.00
OmniAb (OABI)	United States	$0.213B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.186B	0.00
Korro Bio (KRRO)	United States	$0.183B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.174B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.167B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.167B	0.00
Heron Therapeutics (HRTX)	United States	$0.161B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.154B	0.00
Avita Medical (RCEL)	United States	$0.154B	0.00
VAXART, INC (VXRT)	United States	$0.152B	10.50
Galectin Therapeutics (GALT)	United States	$0.151B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.147B	0.00
Journey Medical (DERM)	United States	$0.141B	0.00
Assertio Holdings (ASRT)	United States	$0.116B	0.00
Innate Pharma SA (IPHYF)	France	$0.115B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.107B	0.00
Pyxis Oncology (PYXS)	United States	$0.107B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Vivani Medical (VANI)	United States	$0.088B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.088B	0.00
PolyPid (PYPD)	Israel	$0.082B	0.00
Nuo Therapeutics (AURX)		$0.082B	0.00
Champions Oncology (CSBR)	United States	$0.080B	0.00
Gain Therapeutics (GANX)	United States	$0.076B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.073B	0.00
Fractyl Health (GUTS)	United States	$0.073B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.070B	0.00
Rafael Holdings (RFL)	United States	$0.066B	0.00
Dominari Holdings (DOMH)	United States	$0.065B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.060B	0.00
ElectroCore (ECOR)	United States	$0.049B	0.00
Nutriband (NTRB)	United States	$0.047B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.046B	34.33
SCYNEXIS (SCYX)	United States	$0.045B	0.00
Lite Strategy (LITS)	United States	$0.042B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.042B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Incannex Healthcare (IXHL)	Australia	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Plus Therapeutics (PSTV)	United States	$0.033B	0.00
Tempest Therapeutics (TPST)	United States	$0.029B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
VYNE Therapeutics (VYNE)	United States	$0.020B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Natural Alternatives (NAII)	United States	$0.018B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Lipocine (LPCN)	United States	$0.016B	0.00
Vyome Holdings (HIND)	United States	$0.015B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.014B	0.00
Wellgistics Health (WGRX)	United States	$0.014B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.014B	0.00
Scienture Holdings (SCNX)	United States	$0.014B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
Vivos Therapeutics (VVOS)	United States	$0.013B	0.00
Traws Pharma (TRAW)	United States	$0.012B	0.02
Ainos (AIMD)	United States	$0.012B	0.00
Cosmos Health (COSM)	United States	$0.011B	0.00
Mannatech (MTEX)	United States	$0.011B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.011B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
BioLineRx (BLRX)	Israel	$0.010B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.010B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.010B	0.00
Liminatus Pharma (LIMN)	United States	$0.008B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.008B	0.00
Inotiv (NOTV)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Xenetic Biosciences (XBIO)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.006B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Redhill Biopharma (RDHL)	Israel	$0.004B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.004B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.002B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
CDT Equity (CDT)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00